Ignite Creation Date:
2025-12-25 @ 4:11 AM
Ignite Modification Date:
2025-12-26 @ 3:10 AM
Study NCT ID:
NCT00891020
Status:
COMPLETED
Last Update Posted:
2012-10-25
First Post:
2009-04-29
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-05
Start Date Type:
None
Primary Completion Date:
2010-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-03
Completion Date Type:
ACTUAL
First Submit Date:
2009-04-29
First Submit QC Date:
None
Study First Post Date:
2009-04-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-02-28
Results First Submit QC Date:
None
Results First Post Date:
2012-04-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-10-19
Last Update Post Date:
2012-10-25
Last Update Post Date Type:
ESTIMATED